ES543257A0 - Procedimiento para preparar un polipeptido - Google Patents

Procedimiento para preparar un polipeptido

Info

Publication number
ES543257A0
ES543257A0 ES543257A ES543257A ES543257A0 ES 543257 A0 ES543257 A0 ES 543257A0 ES 543257 A ES543257 A ES 543257A ES 543257 A ES543257 A ES 543257A ES 543257 A0 ES543257 A0 ES 543257A0
Authority
ES
Spain
Prior art keywords
polypeptide
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543257A
Other languages
English (en)
Other versions
ES8802235A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES543257A0 publication Critical patent/ES543257A0/es
Publication of ES8802235A1 publication Critical patent/ES8802235A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES543257A 1984-05-17 1985-05-17 Procedimiento para preparar un polipeptido Expired ES8802235A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848412564A GB8412564D0 (en) 1984-05-17 1984-05-17 Structure and properties

Publications (2)

Publication Number Publication Date
ES543257A0 true ES543257A0 (es) 1988-04-16
ES8802235A1 ES8802235A1 (es) 1988-04-16

Family

ID=10561073

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543257A Expired ES8802235A1 (es) 1984-05-17 1985-05-17 Procedimiento para preparar un polipeptido

Country Status (7)

Country Link
US (2) US4769233A (es)
EP (1) EP0163993A3 (es)
JP (1) JPS6156200A (es)
AU (1) AU589560B2 (es)
ES (1) ES8802235A1 (es)
GB (1) GB8412564D0 (es)
ZA (1) ZA853750B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
DE3712564A1 (de) * 1987-04-14 1988-11-24 Bioferon Biochem Substanz Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US6682896B1 (en) * 1988-10-14 2004-01-27 Schering Aktiengesellschaft Peptides representing epitopic sites on r-IFN-β, antibodies thereto and uses thereof
WO1990003982A1 (en) * 1988-10-14 1990-04-19 Triton Biosciences, Inc. Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
IL89662A (en) * 1989-03-19 1997-11-20 Interpharm Lab Ltd Kiryat Weiz Pharmaceutical compositions comprising interferon-beta
US5545723A (en) * 1994-03-15 1996-08-13 Biogen Inc. Muteins of IFN-β
DE19717864C2 (de) 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DK1656952T3 (da) 1998-10-16 2014-01-20 Biogen Idec Inc Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
DK1121382T3 (da) * 1998-10-16 2006-11-13 Biogen Idec Inc Interferon-beta-fusionsproteiner og deres anvendelser
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US6531122B1 (en) * 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
US7431921B2 (en) * 1999-08-27 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) * 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US20020169290A1 (en) * 2000-11-02 2002-11-14 Claus Bornaes New multimeric interferon beta polypeptides
EP2080771A3 (en) 2001-02-27 2010-01-06 Maxygen Aps New interferon beta-like molecules
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
EP2327724A3 (en) 2004-02-02 2011-07-27 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
AR053284A1 (es) * 2005-05-19 2007-04-25 Schering Ag Terapia genica de interferon -beta usando un sistema mejorado de expresion regulada
CN101238214A (zh) * 2005-05-19 2008-08-06 拜尔先灵制药股份公司 使用改进的调节表达系统治疗疾病
US20070179113A1 (en) * 2005-05-19 2007-08-02 Schering Aktiengesellachaft GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
US20080076729A1 (en) * 2005-05-19 2008-03-27 Schering Aktiengesellachaft Interferon-beta gene therapy using an improved, regulated expression system
US20080038224A1 (en) * 2006-03-28 2008-02-14 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
WO2008021412A2 (en) * 2006-08-14 2008-02-21 Biorexis Pharmaceutical Corporation Interferon beta and transferrin fusion proteins
WO2008125222A2 (en) * 2007-04-11 2008-10-23 Bayer Schering Pharma Aktiengesellschaft New modulation molecules for an improved regulated expression system
MX2009011870A (es) * 2007-05-02 2009-11-12 Ambrx Inc Polipeptidos de interferon beta modificados y usos de los mismos.
US7625555B2 (en) * 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
US8273561B2 (en) * 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
MX2010005317A (es) 2007-11-20 2010-06-02 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
MA34521B1 (fr) 2010-08-17 2013-09-02 Ambrx Inc Polypeptides de relaxine modifiés et leurs utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor

Also Published As

Publication number Publication date
AU589560B2 (en) 1989-10-19
US4914033A (en) 1990-04-03
EP0163993A3 (en) 1988-03-16
ZA853750B (en) 1986-07-30
EP0163993A2 (en) 1985-12-11
JPS6156200A (ja) 1986-03-20
ES8802235A1 (es) 1988-04-16
GB8412564D0 (en) 1984-06-20
US4769233A (en) 1988-09-06
AU4256185A (en) 1985-11-28

Similar Documents

Publication Publication Date Title
ES542311A0 (es) Procedimiento para preparar un polipeptido
ES543257A0 (es) Procedimiento para preparar un polipeptido
ES548307A0 (es) Un procedimiento para preparar polipeptidos
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES551519A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES529523A0 (es) Procedimiento para preparar un analogo polipeptido inhibidor de renina
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES545386A0 (es) Un procedimiento para preparar un organotitanato
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES543973A0 (es) Procedimiento para preparar peptidos
ES524245A0 (es) Procedimiento para obtener un polipeptido
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES547004A0 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES550002A0 (es) Un procedimiento para preparar un poliuretano
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES535455A0 (es) Un procedimiento para preparar peptidos
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES540784A0 (es) Un procedimiento para preparar compuestos relacionados con espergualina
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES546530A0 (es) Un procedimiento para preparar un polipeptido hibrido.
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506